Skip to main content
. 2020 Jan 13;48(4):1271–1280. doi: 10.1007/s10439-020-02449-5

Figure 5.

Figure 5

HUVEC (gray line) and C3A (black line) viability as a function of increasing target cell doses. Panels show the viability as measured by the Alamar blue assay at 6 h (a), 16 h (b) and 24 h (c). Data shown as mean ± std (n = 4).